Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study

Gilad Sherman; Gabriella S. Lamb; Tanvi S. Sharma; Elizabeth C. Lloyd; Jerod Nagel; Nada N. Dandam; Carlos R. Oliveira; Hassan S. Sheikha; Brenda I. Anosike; Philip Lee; Surabhi B. Vora; Karisma Patel; Paul K. Sue; Beenish Rubbab; April M. Yarbrough; Lakshmi Ganapathi; Mari M. Nakamura

doi:10.1093/jpids/piac124

Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study

Gilad Sherman, Gabriella S. Lamb, Tanvi S. Sharma, Elizabeth C. Lloyd, Jerod Nagel, Nada N. Dandam, Carlos R. Oliveira, Hassan S. Sheikha, Brenda I. Anosike, Philip Lee, Surabhi B. Vora, Karisma Patel, Paul K. Sue, Beenish Rubbab, April M. Yarbrough, Lakshmi Ganapathi, Mari M. Nakamura

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Monoclonal antibodies for COVID-19 are authorized in high-risk patients aged ≥12 years, but evidence in pediatric patients is limited. In our cohort of 142 patients treated at seven pediatric hospitals between 12/1/20 and 7/31/21, 9% developed adverse events, 6% were admitted for COVID-19 within 30 days, and none received ventilatory support or died.

Original language	English (US)
Pages (from-to)	152-155
Number of pages	4
Journal	Journal of the Pediatric Infectious Diseases Society
Volume	12
Issue number	3
DOIs	https://doi.org/10.1093/jpids/piac124
State	Published - Mar 1 2023
Externally published	Yes

Keywords

COVID-19
SARS-CoV-2
bamlanivimab and etesevimab
casirivimab and imdevimab
monoclonal antibodies
pediatric

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jpids/piac124

Cite this

Sherman, G., Lamb, G. S., Sharma, T. S., Lloyd, E. C., Nagel, J., Dandam, N. N., Oliveira, C. R., Sheikha, H. S., Anosike, B. I., Lee, P., Vora, S. B., Patel, K., Sue, P. K., Rubbab, B., Yarbrough, A. M., Ganapathi, L., & Nakamura, M. M. (2023). Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study. Journal of the Pediatric Infectious Diseases Society, 12(3), 152-155. https://doi.org/10.1093/jpids/piac124

Sherman, G, Lamb, GS, Sharma, TS, Lloyd, EC, Nagel, J, Dandam, NN, Oliveira, CR, Sheikha, HS, Anosike, BI , Lee, P, Vora, SB, Patel, K, Sue, PK, Rubbab, B, Yarbrough, AM, Ganapathi, L & Nakamura, MM 2023, 'Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study', Journal of the Pediatric Infectious Diseases Society, vol. 12, no. 3, pp. 152-155. https://doi.org/10.1093/jpids/piac124

@article{b87846a56be847c8a5599af551d6b0df,

title = "Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study",

abstract = "Monoclonal antibodies for COVID-19 are authorized in high-risk patients aged ≥12 years, but evidence in pediatric patients is limited. In our cohort of 142 patients treated at seven pediatric hospitals between 12/1/20 and 7/31/21, 9% developed adverse events, 6% were admitted for COVID-19 within 30 days, and none received ventilatory support or died.",

keywords = "COVID-19, SARS-CoV-2, bamlanivimab and etesevimab, casirivimab and imdevimab, monoclonal antibodies, pediatric",

author = "Gilad Sherman and Lamb, {Gabriella S.} and Sharma, {Tanvi S.} and Lloyd, {Elizabeth C.} and Jerod Nagel and Dandam, {Nada N.} and Oliveira, {Carlos R.} and Sheikha, {Hassan S.} and Anosike, {Brenda I.} and Philip Lee and Vora, {Surabhi B.} and Karisma Patel and Sue, {Paul K.} and Beenish Rubbab and Yarbrough, {April M.} and Lakshmi Ganapathi and Nakamura, {Mari M.}",

year = "2023",

month = mar,

day = "1",

doi = "10.1093/jpids/piac124",

language = "English (US)",

volume = "12",

pages = "152--155",

journal = "Journal of the Pediatric Infectious Diseases Society",

issn = "2048-7193",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients

T2 - A Multicenter Retrospective Study

AU - Sherman, Gilad

AU - Lamb, Gabriella S.

AU - Sharma, Tanvi S.

AU - Lloyd, Elizabeth C.

AU - Nagel, Jerod

AU - Dandam, Nada N.

AU - Oliveira, Carlos R.

AU - Sheikha, Hassan S.

AU - Anosike, Brenda I.

AU - Lee, Philip

AU - Vora, Surabhi B.

AU - Patel, Karisma

AU - Sue, Paul K.

AU - Rubbab, Beenish

AU - Yarbrough, April M.

AU - Ganapathi, Lakshmi

AU - Nakamura, Mari M.

PY - 2023/3/1

Y1 - 2023/3/1

N2 - Monoclonal antibodies for COVID-19 are authorized in high-risk patients aged ≥12 years, but evidence in pediatric patients is limited. In our cohort of 142 patients treated at seven pediatric hospitals between 12/1/20 and 7/31/21, 9% developed adverse events, 6% were admitted for COVID-19 within 30 days, and none received ventilatory support or died.

AB - Monoclonal antibodies for COVID-19 are authorized in high-risk patients aged ≥12 years, but evidence in pediatric patients is limited. In our cohort of 142 patients treated at seven pediatric hospitals between 12/1/20 and 7/31/21, 9% developed adverse events, 6% were admitted for COVID-19 within 30 days, and none received ventilatory support or died.

KW - COVID-19

KW - SARS-CoV-2

KW - bamlanivimab and etesevimab

KW - casirivimab and imdevimab

KW - monoclonal antibodies

KW - pediatric

UR - http://www.scopus.com/inward/record.url?scp=85146657015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85146657015&partnerID=8YFLogxK

U2 - 10.1093/jpids/piac124

DO - 10.1093/jpids/piac124

M3 - Article

C2 - 36928172

AN - SCOPUS:85146657015

SN - 2048-7193

VL - 12

SP - 152

EP - 155

JO - Journal of the Pediatric Infectious Diseases Society

JF - Journal of the Pediatric Infectious Diseases Society

IS - 3

ER -

Monoclonal Antibody Use for Coronavirus Disease 2019 in Pediatric Patients: A Multicenter Retrospective Study

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this